# Feru-guard for Behavioral Symptoms in Dementia

> **NCT03451760** · PHASE2 · UNKNOWN · sponsor: **Glovia Co., Ltd.** · enrollment: 70 (estimated)

## Conditions studied

- Behavioral and Psychiatric Symptoms of Dementia

## Interventions

- **DRUG:** Feru-guard 100M
- **OTHER:** Feru-guard 100M Placebo

## Key facts

- **NCT ID:** NCT03451760
- **Lead sponsor:** Glovia Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2018-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03451760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03451760, "Feru-guard for Behavioral Symptoms in Dementia". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03451760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*